This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wight, E. Articles by Lüscher, T. F. Search for Related Content PubMed PubMed Citation Articles by Wight, E. Articles by Küng, C. F. Articles by Moreau, P. Articles by Takase, H. Articles by Lüscher, T. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Pressure Medicines Social Bookmarking                         What's this?

Chronic Blockade of Nitric Oxide-Synthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Pregnancy Outcome

Christoph F. Küng, PhD

Pierre Moreau, PhD

Hiroyuki Takase, MD

Department of Obstetrics and Gynecology, University Hospital Zürich, Zürich; Cardiovascular Research, Cardiology, Inselspital/University Hospital, Bern. Switzerland

Thomas F. Lüscher, MD

Department of Obstetrics and Gynecology, University Hospital Zürich, Zürich; Cardiovascular Research, Cardiology, Inselspital/University Hospital, Bern. Switzerland; University Hospital, CH-8091 ürich, Switzerland; 100771.1237{at}Compuserve.com

Objectives: To investigate the effects of endotheline-1 (ET-1) receptor antagonism and/or chronic blockade of nitric oxide (NO) production on pregnancy outcome in the rat.

Methods: Pregnant or nonpregnant Wistar rats were either treated orally for up to 18 days with the NO-synthase inhibitor N-nitro-L-arginine methyl estr (L-NAME), the ET_A-/ET_B-receptor antagonist bosentan (Roche Basel, Switzerland) or both, or received no treatment (controls). Blood pressure, body weight, and drug intake were measured intervals. Pregnancy outcome and proteinurea were also determined. Analysis of variance and paired Student t test were used for statistical analysis.

Results: Chronic L-NAME treatment increased systolic blood pressure by 69 and 64 mmHg in pregnant and virgin rats respectively (P < .05). Bosentan-blunted, L-NAME-induced hypertension at the beginning (P < .05), but not at the end of the treatment period in all rats examined. N-nitro-L-arginine methyl ester-treatment in pregnancy reduced the number of living fetuses at term (P < .05) and caused proteinurea (P < .05). Bosentan tended to reverse the effects of L-NAME on fetus number and proteinurea, but both effects failed to reach statistical significance.

Conclusions: The effects of chronic NO-synthase-blockade on blood pressure in gravid rats can be reversed only temporarily by ET_A-/ET_B-antagonism, suggesting an involvement of endothelin-1 in the early phase of the L-NAME-induced, preeclampsia-like syndrome during pregnancy, although at later stages other mechanisms may come into play.

Key Words: Acetylcholine • bosentan • endothelin-1 • N-nitro-L-arginine methyl ester (L-NAME) • preeclampsia • rat pregnancy

Journal of the Society for Gynecologic Investigation, Vol. 5, No. 3, 132-139 (1998)
DOI: 10.1177/107155769800500305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?